PPMDB.org logo

The Precautionary and Prohibited Medications Database

Maintained by a collaboration of the University at Buffalo Pharmacology Specialty Laboratory and Frontier Science & Technology Research Foundation

Click Show Protocol Text to get text to copy and paste into a protocol document.

Medication Information

Display Name Glecaprevir/​Pibrentasvir
Medication Class Anti-HCV
Abbreviations
Alternative Names
Chemical Name ABT-493/ABT-530
Brand Names MAVYRET
Components ABT-493, ABT-530, PIB, Glecaprevir, Pibrentasvir
Generic Names
Number of prohibited interactions 5
Number of precautionary interactions 4
Number of unknown or no interactions 13
Total number of interactions 22

Medications that interact with Glecaprevir/​Pibrentasvir

Interacting Medication Designation Last Updated
Atazanavir Prohibited 01-Mar-2022 View Details
Buprenorphine/Naloxone Unknown or no reaction View Details
Caffeine Unknown or no reaction 20-Jul-2018 View Details
Cyclosporine Precautionary View Details
Dabigatran Prohibited 23-Jul-2018 View Details
Darunavir/Ritonavir Prohibited 01-Mar-2022 View Details
Dextromethorphan Unknown or no reaction 20-Jul-2018 View Details
Dolutegravir/Abacavir/Lamivudine Unknown or no reaction 01-Mar-2022 View Details
Efavirenz Prohibited 01-Mar-2022 View Details
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Unknown or no reaction 01-Mar-2022 View Details
Lopinavir/Ritonavir Prohibited 01-Mar-2022 View Details
Losartan Unknown or no reaction 20-Jul-2018 View Details
Methadone Unknown or no reaction View Details
Midazolam Unknown or no reaction 20-Jul-2018 View Details
Omeprazole Unknown or no reaction 20-Jul-2018 View Details
Pravastatin Precautionary 23-Jul-2018 View Details
Raltegravir Unknown or no reaction 01-Mar-2022 View Details
Rilpivirine Unknown or no reaction 01-Mar-2022 View Details
Rosuvastatin Precautionary 23-Jul-2018 View Details
Tacrolimus Precautionary View Details
Tolbutamide Unknown or no reaction 20-Jul-2018 View Details
Valsartan Unknown or no reaction 20-Jul-2018 View Details